ArticleMolecular cancer therapeutics2025

Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti-PD-1 Shows Response in Murine Immunological T-cell-High and T-cell-Low PDAC Models.

Roisin McMorrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.